The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Elevating Consciousness of Monetary Struggles Confronted by AYA Most cancers Survivors

March 31 by way of April 6 is acknowledged as Adolescent and Younger Grownup (AYA) Most cancers Consciousness Week, bringing collectively organizations throughout...

What Position Does MRD Play in A number of Myeloma Remedy Choice Making?

Dr. Surbhi Sidana mentioned the subject of minimal residual illness: nobeastsofierce - inventory.adobe.comThe query of whether or not minimal residual illness may help...

Dive Into March 2025 FDA Approvals Throughout Most cancers Subtypes

March 2025 U.S. FDA approvals throughout most cancers subtypes, together with prostate, bladder and gastrointestinal cancers.Over the course of March, the U.S. Meals...

What To Know About Having Radiation for Metastatic Prostate Most cancers

Chester Freeman was identified with bladder most cancers and most lately with persistent lymphocytic leukemia (CLL). Learn Chester's blogs right here!As a caregiver, I...

First Affected person Dosed With Annamycin and Cytarabine in Section 3 AML Trial

First affected person with relapsed or refractory acute myeloid leukemia dosed with Annamycin plus Cytarabine within the international section 3 MIRACLE trial.The primary...

Hot Topics